Current Opinion in Rheumatology

• Developments In Lung Disease in Pediatric Rheumatic Disease These findings provide new insights into our understanding of pulmonary complications of rheumatic disease in children.
  Current Opinion in Rheumatology, August 23, 2023
• Pelvic Radiography as First Imaging Modality in Sacroiliitis Pelvic radiographs are recommended as the first imaging test in the diagnostic work up of patients with suspected sacroiliitis, but are there more accurate alternatives?
  Current Opinion in Rheumatology, June 21, 2023
• Autoantibodies in Monitoring and Treatment of Scleroderma Learn more about the role antinuclear autoantibodies could have in the management and treatment of scleroderma.
  Current Opinion in Rheumatology, October 26, 2022
• EASD 2022
  September 22, 2022
• ESMO 2022
  September 09, 2022
• Biologic DMARDS to Treat MIS-C Biologic DMARDs may be an effective means of treating multisystem inflammatory syndrome among children who did not adequately respond to initial treatment strategies.
  Current Opinion in Rheumatology, September 09, 2022
• ESC 2022
  August 26, 2022
• NSAIDs and CVD Risk in Spondyloarthritis-Spectrum Diseases Spondyloarthritis is known to be associated with an increased risk of cardiovascular disease. Might the use of NSAIDs further exacerbate the risk among these patients?
  Current Opinion in Rheumatology, August 09, 2022
• ECO 2022
  May 05, 2022
• Advances in the Clinical Use of Hydroxychloroquine Levels What role could the assessment of hydroxychloroquine levels have in the management of patients with lupus?
  Current Opinion in Rheumatology, May 05, 2022
• ECCMID 2022
  April 21, 2022
• ACC 2022
  April 20, 2022
• BSH 2022
  April 20, 2022
• DUKPC 2022
  April 01, 2022
• Update on Gout Management: What Is Old and What Is New Get up-to-date on the most recent advances in the management of gout.
  Current Opinion in Rheumatology, February 16, 2022
• Environmental Triggers for Connective Tissue Disease What is the link between COVID-19 infection and connective tissue diseases?
  Current Opinion in Rheumatology, January 10, 2022
• SfE BES 2021
  November 12, 2021
• NCRI 2021
  November 12, 2021
• DPC 2021
  November 12, 2021
• AHA 2021
  November 10, 2021
• RCP Med+ 2021
  October 26, 2021
• RCGP 2021
  October 14, 2021
• Update on COVID-19 in Immune-Mediated Inflammatory Disease This article provides an update on our current knowledge regarding COVID-19 outcomes and vaccine responses among patients with immune-mediated inflammatory diseases.
  Current Opinion in Rheumatology, October 04, 2021
• EASD 2021
  September 30, 2021
• ESMO 2021
  September 30, 2021
• ESOC 2021
  September 30, 2021
• BCS 2021
  September 30, 2021
• ERS 2021
  September 28, 2021
• ARM 2021
  September 20, 2021
• Twenty Years of Clinical Trials in Axial Spondyloarthritis What have we learned about the treatment of axial spondyloarthritis and how can these lessons apply to future investigations?
  Current Opinion in Rheumatology, June 11, 2021
• Quinacrine: Au Revoir or Adieu? Quinacrine is a safe and effective antimalarial agent. Does it have a place in the treatment of lupus?
  Current Opinion in Rheumatology, April 20, 2021
• Covid-19 and Autoimmune Diseases A new review explores the relationship between COVID-19 and autoimmunity and the potential impact of the virus on those with pre-existing autoimmune diseases.
  Current Opinion in Rheumatology, February 15, 2021
• Recent Advances in Targeted Drug Delivery for Osteoarthritis Get up-to-date on the latest developments in targeted drug delivery for osteoarthritis treatment.
  Current Opinion in Rheumatology, December 17, 2020
• Update on Antimalarials and Systemic Lupus Erythematosus A new review provides an update on recent evidence regarding the use of antimalarials in systemic lupus erythematosus.
  Current Opinion in Rheumatology, October 22, 2020
• COVID-19: A Primer for the Rheumatologist How should patients with immune-mediated inflammatory diseases be managed during the COVID-19 pandemic? A new review discusses current recommendations.
  Current Opinion in Rheumatology, August 20, 2020
• Physical Therapy in Axial Spondyloarthritis What role does physical therapy have in the management of axial spondyloarthritis? What amount of exercise is most effective?
  Current Opinion in Rheumatology, June 15, 2020
• Antirheumatic Medications in Pregnancy and Breastfeeding When it comes to the risks and benefits of antirheumatic medications during pregnancy, what do rheumatologists need to know?
  Current Opinion in Rheumatology, April 14, 2020
• Debates in Gout Management This review provides an update on the most current research that may impact gout management.
  Current Opinion in Rheumatology, February 13, 2020
• Immune Checkpoint Inhibitors and Vasculitis Is immune checkpoint inhibitor therapy associated with the development of vasculitis among cancer patients?
  Current Opinion in Rheumatology, December 17, 2019
• Cardiovascular Risks in Spondyloarthritides Spondyloarthritides are associated with increased CV risks, partly due to traditional risk factors. This review discusses cardiac and vascular pathologies and potential overlapping mechanisms.
  Current Opinion in Rheumatology, July 25, 2020